Neurology Central

Could aspirin help reduce Alzheimer’s-related amyloid plaques?

According to scientists at Rush University Medical Center (IL, USA), a low-dose regimen of aspirin may reduce Alzheimer’s-related amyloid plaques in the brain – indicating a potential new role for this medication. The researchers believe that this could reduce Alzheimer’s disease (AD) pathology and protect memory.

Aspirin is one of the most widely used over-the-counter medications in the world, and works by activating PPARα to upregulate TFEB and increase lysosomal biogenesis in brain cells. TFEB is known as a master regulator of lysosomal biogenesis.

Restricted Content / Members Only

You cannot view this content because It is available to members only. Please or Register to view this area.